Abstract
INTRODUCTION
The incidence of contrast-induced nephropathy (CIN) is increasing owing to the increasing use of contrast media in percutaneous coronary intervention (PCI). CIN is an adverse event that results in an increased risk of morbidity and mortality during hospitalization, prolongs hospital stay, increases the incidence of chronic end-stage renal disease and increases the cost of healthcare. 1 No adjunctive medical or mechanical treatment has been proved to be efficacious in reducing the risk of CIN. 2 There have been few clinical trials to evaluate the role of Traditional Chinese Medicine (TCM) in the prevention of CIN. The objective of the present study was to evaluate the role of the mushroom Dongchongxiacao (Cordyceps) for the prophylaxis of CIN in patients with stable angina pectoris (SAP) who underwent coronary angiography or coronary intervention.
METHODS

Ethical approval of the study protocol
The study protocol was approved by the Ethics Com-mittee of Tianjin Nankai Hospital (Tianjin, China). All patients provided written informed consent to be included in this study.
Study population
The present study was conducted at the Department of Cardiology at Tianjin Nankai Hospital from October 2011 to September 2012. Samples were selected by using a Random Number Table. One hundred and three eligible patients with SAP were divided randomly into two groups: basic treatment (n=51) and Dongchongxiacao (Cordyceps) (DCXC) treatment (n=52). Subjects had to be >18 years and <80 years of age, and SAP had to conform to guidelines set by the relevant organization in China in 2007. 3 The exclusion criteria were patients that were hyperpyrexic or allergic to iodine or who had: tumors: severe heart failure; severe liver or kidney failure; disorders of the immune system; blood diseases. for 6 h before, and 12 h after, contrast exposure. An interventional team carried out PCI according to standard practice using conventional guide catheters, guidewires, balloon catheters and stents via femoral or radial approaches. Decisions regarding the procedure were left to the discretion of the interventional cardiologist. All procedures were undertaken with low-osmolarity non-ionic contrast media (iopamidol, i.v.). The volume of contrast media used was recorded for all patients during catheterization.
Intervention
Outcome measures
Serum levels of triglycerides (TG), total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), uric acid, and fibrinogen were assessed at the time of hospital admission. Serum creatinine (Scr) was assessed at the time of hospital admission and 1, 2, and 3 days after the procedure. Values of kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL) and interleukin (IL) 18 in urine were recorded before and 1 day after the procedure in patients of both groups.
Statistical analyses
Continuous variables and categorical variables are the mean±standard deviation (SD) and percentages, respectively. All samples were tested to ascertain if they followed a normal distribution. Comparisons between groups were undertaken using the Student's t-test for independent groups. Categorical variables were compared using the χ 2 test or the Fisher exact test (if appropriate). P<0.05 (two-tailed) were considered significant. Statistical analyses were done using SPSS ver 13.0 (SPSS, Chicago, IL, USA).
RESULTS
Baseline clinical and procedural characteristics are listed in Table 1 . There was no significant difference between the two groups with regard to the general condition for CIN (P>0.05). Overall, CIN occurred in 9 of 103 patients (8.74% ). The prevalence of CIN in the DCXC treatment group was lower than that in the basic treatment group (5.77% vs 11.76%) but this difference was not significant (P>0.05). The mean peak value of Scr and the increase in Scr level from baseline ( Δ Scr) after the procedure in patients in the DCXC treatment group were significantly lower than those in the basic treatment group (P<0.05). Within 3 days after the procedure, all Scr levels were lower in patients in the DCXC treatment group than those in the basic treatment group, but only on day 2 was the difference significant (P<0.05) ( Table 2 ). Within 1 day after the procedure, all urine levels of KIM-1, NGAL, and IL18 in patients in the DCXC treatment group were lower than in those in the basic treatment group (P<0.05) ( Table 3) .
DISCUSSION
CIN is defined as a relative increase in Scr level from a baseline value of ≥25% or an absolute increase of ≥0.5 mg/dL within 3 days after intravascular administration of contrast medium without an alternative etiology. [4] [5] [6] However, the change in Scr level precedes kidney damage and does not demonstrate losses in renal function in a timely manner. Recent studies have suggested that urine levels of KIM-1, NGAL and IL18 can predict the development and progression of CIN. 7, 8 It is widely recognized that the renal ischemia induced by hemodynamic change and renal vascular constriction have major roles in the pathogenesis of CIN. 9 However, recent studies have shown that oxidative stress plays an important part in the development and progression of CIN. 10, 11 In accordance with these observations, antioxidants such as N-acetylcysteine and ascorbic acid have been used in experimental and clinical trials to protect against CIN. 12, 13 Additional evidence of the effectiveness of an antioxidant strategy comes from a recent observation with probucol. Probucol was shown to attenuate renal damage in patients who underwent coronary angiography or coronary intervention. 14 The renal impairment caused by CIN belongs to the categories of Bilong, Guange, and Nidu. Contrast medium can be classified into the TCM category of "medicine poison, hot and humid, blood stasis". CIN involves the lung, spleen, kidney and other viscera. Triple warmer gasification suffocate is the key to pathogenesis of CIN. The essence of CIN belongs to the scope of deficiency syndrome. The pathogenesis specialty of CIN is deficiency origin and excess in superficiality. Table 2 Scr levels at baseline and after the procedure in patients from the two groups Notes: CIN: contrast-induced nephropathy; Scr: serum creatinine. sions in rats. 19 We used Dongchongxiacao (Cordyceps) to prevent CIN. CIN occurred in 9 of 103 patients. The prevalence of CIN in the DCXC treatment group was lower compared with that in the basic treatment group. We selected Δ Scr, peak Scr, and urine levels of KIM-1, NGAL and IL18 after the procedure as an index of renal function. Treatment with Dongchongxiacao (Cordyceps) markedly suppressed the increase in peak values of Scr and Δ Scr. After the procedure, all urine levels of KIM-1, NGAL and IL18 in patients in the DCXC group were lower than those in the basic treatment group. These results strongly suggest the preventative effect of Dongchongxiacao (Cordyceps) on CIN in SAP patients exposed to contrast media. Dongchongxiacao (Cordyceps) can reinforce the kidney, replenish Qi, and strengthen essence. It can also correct obvious primary deficiency syndrome. The present study had a limitation. The study cohort was small, which would have weakened the statistical power of the results. The randomized small-scale study described here showed that prophylactic treatment with Dongchongxiacao (Cordyceps) in SAP patients who undergo coronary angiography or coronary intervention could prevent CIN. Further studies are warranted to clarify the preventative effects of Dongchongxiacao (Cordyceps) on CIN. Table 3 Urine levels of KIM-1, NGAL and IL18 at baseline and after the procedure in patients from the two groups 
